Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio de Lucia

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Cardiovascular Diabetology|October 24, 2018
Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rateCelestino Sardu, Pasquale Paolisso, Cosimo Sacra, et al.
Cell Communication and Signaling : CCS|August 30, 2013
GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractilityNorma C Salazar, Ximena Vallejos, Ashley Siryk, et al.
Frontiers in Medicine|June 30, 2017
microRNA in Cardiovascular Aging and Age-Related Cardiovascular DiseasesClaudio de Lucia, Klara Komici, Giulia Borghetti, et al.
Journal of the American Heart Association|May 22, 2019
Myocardial Strain and Cardiac Output are Preferable Measurements for Cardiac Dysfunction and Can Predict Mortality in Septic MiceMatthew Hoffman, Ioannis D Kyriazis, Anna M Lucchese, et al.
Journal of Diabetes Research|June 29, 2017
Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future PerspectivesGrazia Daniela Femminella, Leonardo Bencivenga, Laura Petraglia, et al.
Frontiers in Pharmacology|September 8, 2017
Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular SystemAlessandro Cannavo, Daniela Liccardo, Klara Komici, et al.
Hypertension (Dallas, Tex. : 1979)|November 13, 2013
Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanismsAshley Bathgate-Siryk, Samalia Dabul, Krunal Pandya, et al.
Journal of Alzheimer'S Disease : JAD|December 5, 2012
β-adrenergic receptors and G protein-coupled receptor kinase-2 in Alzheimer's disease: a new paradigm for prognosis and therapy?Grazia Daniela Femminella, Giuseppe Rengo, Gennaro Pagano, et al.
Plos One|January 10, 2013
Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysisGiuseppe Rengo, Gennaro Pagano, Alessandro Squizzato, et al.
Frontiers in Physiology|January 7, 2014
Neuro-hormonal effects of physical activity in the elderlyGrazia D Femminella, Claudio de Lucia, Paola Iacotucci, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Cardiovascular Diabetology|October 24, 2018
Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rateCelestino Sardu, Pasquale Paolisso, Cosimo Sacra, et al.
Cell Communication and Signaling : CCS|August 30, 2013
GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractilityNorma C Salazar, Ximena Vallejos, Ashley Siryk, et al.
Frontiers in Medicine|June 30, 2017
microRNA in Cardiovascular Aging and Age-Related Cardiovascular DiseasesClaudio de Lucia, Klara Komici, Giulia Borghetti, et al.
Journal of the American Heart Association|May 22, 2019
Myocardial Strain and Cardiac Output are Preferable Measurements for Cardiac Dysfunction and Can Predict Mortality in Septic MiceMatthew Hoffman, Ioannis D Kyriazis, Anna M Lucchese, et al.
Journal of Diabetes Research|June 29, 2017
Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future PerspectivesGrazia Daniela Femminella, Leonardo Bencivenga, Laura Petraglia, et al.
Frontiers in Pharmacology|September 8, 2017
Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular SystemAlessandro Cannavo, Daniela Liccardo, Klara Komici, et al.
Hypertension (Dallas, Tex. : 1979)|November 13, 2013
Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanismsAshley Bathgate-Siryk, Samalia Dabul, Krunal Pandya, et al.
Journal of Alzheimer'S Disease : JAD|December 5, 2012
β-adrenergic receptors and G protein-coupled receptor kinase-2 in Alzheimer's disease: a new paradigm for prognosis and therapy?Grazia Daniela Femminella, Giuseppe Rengo, Gennaro Pagano, et al.
Plos One|January 10, 2013
Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysisGiuseppe Rengo, Gennaro Pagano, Alessandro Squizzato, et al.
Frontiers in Physiology|January 7, 2014
Neuro-hormonal effects of physical activity in the elderlyGrazia D Femminella, Claudio de Lucia, Paola Iacotucci, et al.
Pageof 6